在药监监测中报告不成比例性分析:聚焦READUS-PV指南
Michele Fusaroli1, Francesco Salvo2,3, Charles Khouri4,5
1Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Frontiers in pharmacology
|December 12, 2024
概括
不成比例性分析对于检测药物不良反应至关重要. 新的READUS-PV指南提高了报告这些药监测研究的透明度和可重复性,确保了更好的药物安全性.
科学领域:
- 药物监督和药物安全研究
- 医疗保健中的生物统计学
- 监管科学 监管科学
背景情况:
- 不成比例性分析被广泛用于营销后监测,以从个体病例安全报告 (ICSR) 中识别潜在的药物不良反应 (ADR).
- 由于可访问的数据库,关于不成比例分析的出版物数量呈指数级增长,但这引发了对结果透明度和准确解释的担忧.
- 缺乏标准化的报告可以导致不合理的警报或模糊真正的安全信号,阻碍有效的药物安全监测.
研究的目的:
- 引入 READUS-PV 指南,这是第一个旨在协调不成比例分析报告的合作倡议.
- 解决越来越多的关于透明度,可重复性和药物监督中不成比例性分析的潜在误解的担忧.
主要方法:
- 通过合作倡议开发READUS-PV指南.
- 专注于建立针对不成比例性分析的标准化报告实践.
- 涉及创建检查清单,以协助研究人员,监管机构和审查人员.
主要成果:
- 该READUS-PV指南为不成比例分析的一致和透明报告提供了一个框架.
- 通过指南的检查清单,预计将提高这些研究的报告,评估和出版的质量.
- 该指南旨在提高不成比例分析结果的可靠性和可解释性.
结论:
- 该READUS-PV指南对于提高药监研究的透明度和可重复性至关重要.
- 建议通过药理学期刊进行全球认可,以确保广泛采用和有效实施.
- 有效传播和实施READUS-PV将支持最优地使用不成比例性分析来确保药物安全.
相关概念视频
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Analysis of Population Pharmacokinetic Data
232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Volume of Distribution
116
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
116
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
81
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
81


